Exelixis Inc (EXEL)
37.01
-0.70
(-1.86%)
USD |
NASDAQ |
Mar 26, 16:00
36.99
-0.02
(-0.05%)
Pre-Market: 08:34
Exelixis Profit Margin (Quarterly): 24.68% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 45.98% |
| Biomarin Pharmaceutical Inc | 16.72% |
| Incyte Corp | 17.07% |
| Catalyst Pharmaceuticals Inc | 39.44% |
| Blueprint Medicines Corp | -34.13% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.63% |
| Return on Assets | 18.07% |
| Return on Invested Capital | 23.63% |
| Gross Profit Margin (Quarterly) | 96.48% |
| Operating Margin (Quarterly) | 28.84% |
| Return on Net Operating Assets | 64.84% |